Nordic Capital is to acquires a majority share in IntegriChain, a provider of pharmaceutical technology, data, consulting, and outsourcing solutions designed to improve how life sciences products reach customers.
IntegriChain delivers ICyte, a fully integrated platform for commercialisation and market access, helping manufacturers bring their science to market while ensuring patients have affordable, timely, and sustainable access to therapy.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Nordic Capital is acquiring the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
Terms of the transaction, which is expected to complete before the end of the year subject to customary closing conditions, have not been disclosed.
Source: PrivateEquityWire
Can’t stop reading? Read more
AllianzGI and TotalEnergies commit $550m to German battery storage portfolio
AllianzGI and TotalEnergies commit $550m to German battery storage portfolio Allianz Global...
Blackstone consortium tables bid for $1.5bn UK aerospace supplier Senior
Blackstone consortium tables bid for $1.5bn UK aerospace supplier Senior Blackstone has joined a...
Neuberger Berman leads $500m Nvidia-backed Ayar Labs round at $3.75bn valuation
Neuberger Berman leads $500m Nvidia-backed Ayar Labs round at $3.75bn valuation Neuberger Berman...